Disclosed is a vaccine comprising bacterial ghosts, tumour associated antigens and antigen presenting cells, for use in tumour immunotherapy. Where the antigen presenting cells are comprised of either dendritic cells or monocytes； the bacterial ghosts are comprised of gram negative bacteria； and the tumour associated antigens are either loaded, recombinantly expressed, or carried by the bacterial ghosts.
